Valeant Pharmaceuticals International Inc. Contracts

Sample Business Contracts from Valeant Pharmaceuticals International Inc.

Agreement and Plan of Merger - Coria Laboratories Ltd. and Valeant Pharmaceuticals International (Sep 16, 2008)
Agreement and Plan of Merger - Medicis Pharmaceutical Corp. and Valeant Pharmaceuticals International Inc. (Sep 2, 2012)
Agreement and Plan of Merger - Valeant Pharmaceuticals International Inc. and Bausch & Lomb Holdings Inc. (May 24, 2013)
Agreement and Plan of Merger - Valeant Pharmaceuticals International Inc. and Salix Pharmaceuticals Ltd. (Feb 20, 2015)
Agreement and Plan of Merger [Amendment No. 1] - Valeant Pharmaceuticals International and Bausch & Lomb Holdings Inc. (Aug 2, 2013)
Agreement and Plan of Merger [Amendment No. 1] - Valeant Pharmaceuticals International and Dow Pharmaceutical Sciences Inc. (Sep 29, 2009)
Agreement and Plan of Merger [Amendment No. 1] - Valeant Pharmaceuticals International and Salix Pharmaceuticals Ltd. (Mar 16, 2015)
Agreement and Plan of Merger [Amendment No. 2] - Valeant Pharmaceuticals International and Bausch & Lomb Holdings Inc. (Aug 5, 2013)
Agreement and Plan of Merger [Amendment] - Coria Laboratories Ltd. and Valeant Pharmaceuticals International (Oct 15, 2008)
Asset Purchase Agreement - Janssen Pharmaceuticals Inc., Valeant International (Barbados) SRL and Valeant Pharmaceuticals North America LLC (Jul 15, 2011)
Asset Purchase Agreement - Sanofi, Valeant International (Barbados) SRL and Valeant Pharmaceuticals International Inc. (Jul 8, 2011)
Asset Purchase Agreement - Three Rivers Pharmaceuticals LLC and Valeant Pharmaceuticals North America (Dec 19, 2007)
Asset Purchase Agreement [Amendment] - Valeant Pharmaceuticals North America and Three Rivers Pharmaceuticals LLC (Jan 11, 2008)
Assignment and Assumption Agreement - Metabasis Therapeutics Inc., Schering Corp. and Valent Research & Development (Dec 13, 2006)
By-Laws - Valeant Pharmaceuticals International
Commitment Letter - JPMorgan Chase Bank NA, JP Morgan Securities LLC and Valeant Pharmaceuticals International Inc. (Sep 2, 2012)
Common Stock Purchase Warrant - Valeant Pharmaceuticals International (Aug 17, 2009)
Contract Manufacture Agreement - Cambridge Laboratories Ltd. and Laboratories Fournier SA (May 9, 2005)
Corporate Integrity Agreement - Department of Health and Human Services and Biovail Corp. (Sep 11, 2009)
Credit and Guaranty Agreement - Valeant Pharmaceuticals International Inc. (Feb 13, 2012)
Credit and Guaranty Agreement - Valeant Pharmaceuticals International Inc. and Goldman Sachs Lending Partners LLC (Aug 10, 2011)
Credit and Guaranty Agreement - Valeant Pharmaceuticals International Inc., Goldman Sachs Lending Partners LLC, JP Morgan Securities LLC and JPMorgan Chase Bank (Oct 20, 2011)
Credit and Guaranty Agreement [Amendment No. 1] - Valeant Pharmaceuticals International and Goldman Sachs Lending Partners LLC (Aug 12, 2011)
Credit and Guaranty Agreement [Amendment No. 1] - Valeant Pharmaceuticals International Inc. and Goldman Sachs Lending Partners LLC (Aug 10, 2011)
Development and License Agreement - Valeant Research & Development and Schering Corp. (Dec 13, 2006)
Directors Share Unit Plan - Valeant Pharmaceuticals International Inc. (May 16, 2011)
Employment Agreement - ICN Pharmaceuticals Inc. and Alan Charles (Dec 3, 2001)
Employment Agreement - ICN Pharmaceuticals Inc. and Clifford R. Saffron (Jan 18, 2001)
Employment Agreement - ICN Pharmaceuticals Inc. and Gregory Keever (Jul 1, 2001)
Employment Agreement - ICN Pharmaceuticals Inc. and Robert O'Leary (Nov 4, 2002)
Employment Agreement - ICN Pharmaceuticals Inc. and Roger D. Loomis Jr. (Nov 16, 2001)
Employment Agreement - PharmaSwiss AG and Pavel Mirovsky (Apr 2, 2012)
Employment Agreement - Valeant Pharmaceuticals International and Elisa Karlson (Aug 25, 2008)
Employment Agreement - Valeant Pharmaceuticals International and Rajiv De Silva (Dec 17, 2008)
Employment Agreement - Valeant Pharmaceuticals International and Steve T. Min (Sep 2, 2008)
Employment Agreement - Valeant Pharmaceuticals International Inc. and Ari Kellen (Dec 30, 2014)
Employment Agreement - Valeant Pharmaceuticals International Inc. and Jason Hanson (Dec 11, 2012)
Employment Agreement - Valeant Pharmaceuticals International Inc. and Laizer Kornwasser (Jan 2, 2013)
Employment Agreement - Valeant Pharmaceuticals International Inc. and Robert Chai-Onn (Jan 13, 2014)
Employment Agreement - Valeant Pharmaceuticals International Inc. and Robert Rosiello (Jun 10, 2015)
Employment Agreement - Valeant Pharmaceuticals International Inc. and Ryan Weldon (Dec 11, 2012)
Executive Employment Agreement - Biovail Corp. and Michel Chouinard (Aug 13, 2008)
Indenture - Valeant Pharmaceuticals International (Oct 4, 2012)
Indenture - Valeant Pharmaceuticals International Inc. (Dec 2, 2013)
Indenture - Valeant Pharmaceuticals International Inc. and Bank of New York Mellon Trust Co. (Jan 30, 2015)
Indenture - VPI Escrow Corp. and The Bank of New York Mellon Trust Co. NA (Oct 4, 2012)
Joinder Agreement - Valeant Pharmaceuticals International Inc. and Barclays Bank PLC (Apr 1, 2015)
Joinder Agreement - Valeant Pharmaceuticals International Inc. and Barclays Bank PLC (Apr 1, 2015)
Joinder Agreement - Valeant Pharmaceuticals International Inc. and Barclays Bank PLC (Jan 22, 2015)
Joinder Agreement - Valeant Pharmaceuticals International Inc. and Barclays Bank PLC (Jan 22, 2015)
Joinder Agreement - Valeant Pharmaceuticals International Inc. and Goldman Sachs Lending Partners LLC (Feb 6, 2014)
Joinder Agreement - Valeant Pharmaceuticals International Inc. and Goldman Sachs Lending Partners LLC (Feb 6, 2014)
Joinder Agreement - Valeant Pharmaceuticals International Inc. and Goldman Sachs Lending Partners LLC (Aug 5, 2013)
Joinder Agreement - Valeant Pharmaceuticals International Inc. and Goldman Sachs Lending Partners LLC (Dec 11, 2012)
Joinder Agreement - Valeant Pharmaceuticals International Inc. and Goldman Sachs Lending Partners LLC (Oct 2, 2012)
Joinder Agreement - Valeant Pharmaceuticals International Inc. and Goldman Sachs Lending Partners LLC (Sep 11, 2012)
Joinder Agreement - Valeant Pharmaceuticals International Inc. and Goldman Sachs Lending Partners LLC (Jul 9, 2012)
Joinder Agreement - Valeant Pharmaceuticals International Inc. and Goldman Sachs Lending Partners LLC (Jun 14, 2012)
Licence Agreement - Meda Pharma SARL and Valeant International (Barbados) SRL (Jun 29, 2011)
License and Collaboration Agreement [Amendment No. 1] - Valeant Pharmaceuticals North America and Glaxo Group Ltd. (Feb 10, 2009)
Matching Restricted Stock Unit Award Agreement - Valeant Pharmaceuticals International
Matching Restricted Stock Unit Award Agreement - Valeant Pharmaceuticals International Inc. (2014)
Offer Letter - ICN Pharmaceuticals Inc. and Eileen Pruette (Mar 3, 2003)
Offer Letter - Valeant Pharmaceuticals International and Bhaskar Chaudhuri (Mar 10, 2009)
Product Commercialization Agreement - Mylan Pharmaceuticals Inc. and Dow Pharmaceutical Sciences Inc. (Feb 21, 2008)
Project Stratos Commitment Letter - Valeant Pharmaceuticals International Inc., Goldman Sachs Bank USA and Goldman Sachs Lending Partners LLC (May 24, 2013)
Project Sun Commitment Letter - Valeant Pharmaceuticals International Inc., Deutsche Bank, HSBC, Bank of Tokyo-Mitsubishi UFJ Ltd., DNB Capital LLC, DNB Markets Inc., SunTrust Bank and SunTrust Robinson Humphrey Inc. (Feb 20, 2015)
Purchase Agreement - ValueAct Capital Master Fund LP and 0909657 BC Ltd. (Mar 6, 2011)
Purchase Agreement - ValueAct Capital Master Fund LP and Valeant Pharmaceuticals International Inc. (Feb 24, 2011)
Restricted Stock Unit Award Agreement - Valeant Pharmaceuticals International
Restricted Stock Unit Award Grant Notice - Valeant Pharmaceuticals International
Separation Agreement - Valeant Pharmaceuticals International Inc. and Daniel Wechsler (Feb 28, 2014)
Separation Agreement - Valeant Pharmaceuticals International Inc. and Howard B. Schiller (Jul 14, 2015)
Separation Agreement - Valeant Pharmaceuticals International Inc. and Rajiv De Silva (Sep 13, 2012)
Separation and Release Agreement - Valeant Pharmaceuticals International and Wesley P. Wheeler (Dec 13, 2007)
Settlement Agreement - United States and Biovail Corp. (Sep 11, 2009)
Share Unit Grant Agreement - Valeant Pharmaceuticals International Inc. (2014)
Stock Option Grant Agreement - Valeant Pharmaceuticals International Inc. (2014)
Stock Option Grant Agreement - Valeant Pharmaceuticals International Inc.
Trademark and Domain Name License Agreement - GlaxoSmithKline LLC and Biovail Laboratories International SRL
Waiver, Release and Option Agreement - Valeant Pharmaceuticals International and Schering Corp. and Schering-Plough Ltd.